Gabriel Ziegler
Overview
Explore the profile of Gabriel Ziegler including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
58
Citations
1669
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
A generalizable data-driven model of atrophy heterogeneity and progression in memory clinic settings
Baumeister H, Vogel J, Insel P, Kleineidam L, Wolfsgruber S, Stark M, et al.
Brain
. 2024 Apr;
147(7):2400-2413.
PMID: 38654513
Memory clinic patients are a heterogeneous population representing various aetiologies of pathological ageing. It is not known whether divergent spatiotemporal progression patterns of brain atrophy, as previously described in Alzheimer's...
12.
Hayek D, Ziegler G, Kleineidam L, Brosseron F, Nemali A, Vockert N, et al.
Mol Psychiatry
. 2024 Jan;
29(4):992-1004.
PMID: 38216727
Neuroinflammation is a hallmark of Alzheimer's disease (AD) and both positive and negative associations of individual inflammation-related markers with brain structure and cognitive function have been described. We aimed to...
13.
Lehmann N, Aye N, Kaufmann J, Heinze H, Duzel E, Ziegler G, et al.
J Neurosci
. 2023 Oct;
43(50):8637-8648.
PMID: 37875377
The mechanisms subserving motor skill acquisition and learning in the intact human brain are not fully understood. Previous studies in animals have demonstrated a causal relationship between motor learning and...
14.
Schott B, Soch J, Kizilirmak J, Schutze H, Assmann A, Maass A, et al.
iScience
. 2023 Sep;
26(10):107765.
PMID: 37744028
Successful explicit memory encoding is associated with inferior temporal activations and medial parietal deactivations, which are attenuated in aging. Here we used dynamic causal modeling (DCM) of functional magnetic resonance...
15.
Yi Y, Lusebrink F, Ludwig M, Maass A, Ziegler G, Yakupov R, et al.
Neurobiol Aging
. 2023 Jun;
129:137-148.
PMID: 37329853
The noradrenergic locus coeruleus (LC) is one of the protein pathology epicenters in neurodegenerative diseases. In contrast to PET (positron emission tomography), MRI (magnetic resonance imaging) offers the spatial resolution...
16.
Bernal J, Schreiber S, Menze I, Ostendorf A, Pfister M, Geisendorfer J, et al.
Alzheimers Res Ther
. 2023 May;
15(1):97.
PMID: 37226207
Background: White matter hyperintensities (WMH) in subjects across the Alzheimer's disease (AD) spectrum with minimal vascular pathology suggests that amyloid pathology-not just arterial hypertension-impacts WMH, which in turn adversely influences...
17.
Azzarito M, Emmenegger T, Ziegler G, Huber E, Grabher P, Callaghan M, et al.
Neuroimage
. 2023 Apr;
274:120128.
PMID: 37116765
Motor skill learning relies on neural plasticity in the motor and limbic systems. However, the spatial and temporal characteristics of these changes-and their microstructural underpinnings-remain unclear. Eighteen healthy males received...
18.
Heinzinger N, Maass A, Berron D, Yakupov R, Peters O, Fiebach J, et al.
Alzheimers Res Ther
. 2023 Mar;
15(1):50.
PMID: 36915139
Background: The NIA-AA proposed amyloid-tau-neurodegeneration (ATN) as a classification system for AD biomarkers. The amyloid cascade hypothesis (ACH) implies a sequence across ATN groups that patients might undergo during transition...
19.
Yildirim Z, Delen F, Berron D, Baumeister H, Ziegler G, Schutze H, et al.
Alzheimers Res Ther
. 2023 Mar;
15(1):43.
PMID: 36855049
Background: In preclinical Alzheimer's disease, it is unclear why some individuals with amyloid pathologic change are asymptomatic (stage 1), whereas others experience subjective cognitive decline (SCD, stage 2). Here, we...
20.
Gaubert M, DellOrco A, Lange C, Garnier-Crussard A, Zimmermann I, Dyrba M, et al.
Front Psychiatry
. 2023 Jan;
13:1010273.
PMID: 36713907
Background: White matter hyperintensities (WMH), a biomarker of small vessel disease, are often found in Alzheimer's disease (AD) and their advanced detection and quantification can be beneficial for research and...